CMV Infection In Solid Organ Transplantation: Clinical Clues And Prevention Strategies

Main Category: Infectious Diseases / Bacteria / Viruses
Also Included In: Transplants / Organ Donations
Article Date: 28 Feb 2009 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Cytomegalovirus (CMV) infection is an important cause of morbidity and mortality and is the most common viral opportunistic infection in recipients of solid organ transplant (SOT). Currently, no consensus exists regarding the most appropriate method for preventing CMV, and toxicities and threat of drug resistance occasionally limit the utility of existing antiviral agents. Alternative agents are being investigated, but more research is needed before these are approved for use in SOT recipients. It is important for healthcare professionals to be aware of the current and emerging treatment and prevention strategies for CMV disease in SOT recipients.

To address the need for current education on CMV, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary CME newsletter entitled CMV Infection in Solid Organ Transplantation: Clinical Clues and Prevention Strategies. This activity is supported by an educational grant from ViroPharma Incorporated.

The expert faculty for this CME newsletter includes Atul Humar, MD, MSc, FRCPC, Director of Transplant Infectious Diseases and Associate Professor in the Department of Medicine at the University of Alberta in Edmonton, Alberta, Canada, and Sunwen Chou, MD, Professor of Medicine at the Oregon Health & Science University in Portland, Oregon.

"Robert Michael Educational Institute LLC recognizes that continuing medical education plays a crucial role in the provision of quality health care and is dedicated to offering professionals meaningful opportunities for lifelong learning," says President and CEO, Robert M. Colleluori.

RMEI is a medical education company that specializes in independent, certified, and noncertified education. The goal of all certified RMEI educational offerings is to promote a spirit of lifelong learning and continuous professional development. RMEI works closely with medical experts to design activities that improve diagnosis and treatment. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

For other educational opportunities, please visit http://www.RMEI.com.

RMEI
http://www.RMEI.com

Article adapted by Medical News Today from original press release.
Visit our infectious diseases / bacteria / viruses section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
RMEI. "CMV Infection In Solid Organ Transplantation: Clinical Clues And Prevention Strategies." Medical News Today. MediLexicon, Intl., 28 Feb. 2009. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/140631.php>

APA
RMEI. (2009, February 28). "CMV Infection In Solid Organ Transplantation: Clinical Clues And Prevention Strategies." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/140631.php.

Please note: If no author information is provided, the source is cited instead.


Infectious Diseases / Bacteria / Viruses

Most Popular Articles



Follow Our Infectious Diseases News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Infectious Diseases / Bacteria / Viruses Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »